|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Adenoviruses as vectors for gene therapy显示文摘 | Douglas JT Curiel DT | 1997 | Sci Med1997，97，1： | 1 |
| 2 | Gene therapy for cancer显示文摘 | Gomez-Navarro J Curiel DT Douglas JT | 1999 | Eur J Cancer1999，35，3： | 1 |
| 3 | Serum IGF-I,IGF-II,IGFBP-3,and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate,lung,colorectal,and ovarian cancer screening trial显示文摘 | Douglas JB Silverman DT Pollak MN | 2010 | Cancer Epidemiol Biomarkers Prev2010，19，9： | 1 |
| 4 | Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines显示文摘 | Daniel SM Douglas DT Cicek GT | 2006 | Cancer Lett2006，236，2： | 1 |
| 5 | Single-chain antibodies:A therapeutic modality for cancer gene therapy显示文摘 | Leath CA 3rd Douglas JT Curiel DT | 2004 | Int J Oncol2004，24，4： | 1 |
| 6 | Serum IGF- I , IGF-I1 , IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trim 显示文摘 | Douglas JB Silverman DT Poltak MN | 2010 | Cancer Epidemiol Biomarkers Prey2010，19，9： | 1 |
| 7 | Single-chain anti-bodies: A therapeutic modality for cancer gene therapy 显示文摘 | Leath CA 3rd Douglas JT Cufiel DT | 2004 | Int J Oncol2004，24，4： | 1 |
| 8 | Single-chain antibodies:A therapeutic modality for cancer gene therapy显示文摘 | Leath CA Douglas JT Curiel DT | 2004 | Int J Oncol2004，24，4： | 1 |
| 9 | Serum IGF-I, IGF-II,IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial显示文摘 | Douglas JB Silverman DT Pollak MN | 2010 | Cancer Epidemiol Biomarkers Prey2010，19，9： | 1 |
| 10 | Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer inthe prostate, lung, colorectal, and ovarian cancer screening trial 显示文摘 | Douglas JB Silverman DT Pollak MN | 2010 | Cancer Epidemiol Biomarkers Prey2010，19，9： | 1 |
| 11 | Apoptosis as a measure of chemosensitivity to cisplatin and taxol therpy in ovarian cancer cell lines 显示文摘 | Randall KG Douglas DT Tina W | 1997 | Gynecol Oncol1997，65，1： | 1 |
| 12 | Gene therapy for cancer显示文摘 | Gomez-Navarro J Curiel DT Douglas JT | 1999 | Eur J Cancer1999，35，3： | 1 |
| 13 | Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial显示文摘 | Douglas JB Silverman DT Pollak MN | 2010 | Cancer Epidem Biomar2010，19，9： | 1 |
| 14 | Serum IGF-Ⅰ,IGF-Ⅱ,IGFBP-3,and IGF-Ⅰ/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate,lung,colorectal,and ovarian cancer screening trial显示文摘 | Douglas JB Silverman DT Pollak MN | | 0，，09： | 1 |
| 15 | Adenoviruses as vectors for gene therapy显示文摘 | Douglas JT Curiel DT | 1997 | Sci Med1997，97，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员